Search - tctmd.com

Displaying 41 - 60 of 219

Sort: Relevancy | Date

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

Presentation ACC 2023

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

Presenter: Gregg W. Stone

March 05, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Conference News PCR London Valves 2022

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

Shelley Wood

December 01, 2022

News Daily News

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Michael O'Riordan

October 05, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News TCT 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Yael L. Maxwell

September 26, 2022

Presentation TCT 2022

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 337: Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

Presenter: Bahira Shahim

September 18, 2022

Presentation TCT 2022

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

Presenter: edoardo zancanaro

September 18, 2022

Presentation TCT 2022

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Chandrashekar Bohra

September 18, 2022

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

Caitlin E. Cox

July 04, 2022

Presentation TVT 2022

Tips and Tricks to Improve Leaflet Coaptation and Imaging During Tricuspid-TEER

Presenter: Philipp Lurz

June 10, 2022

Presentation TVT 2022

Derivation and Validation of a Risk Score for COAPT-Ineligible Patients Undergoing Transcatheter Edge-To-Edge Repair - the CITE score

Presenter: Andrea Scotti

June 09, 2022

Presentation TVT 2022

Outcomes of Transcatheter Mitral Valve Replacement Versus Edge-to-Edge Repair in Secondary Mitral Regurgitation Patients According to Adapted COAPT Inclusion Criteria

Presenter: Sebastian Ludwig

June 09, 2022

Advertisement

TEER or VAD/Transplant in the Advanced HF Patient With MR?

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

What’s Going to Be Hot at ACC/WCC 2023?

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Pascal TEER Device Performs Well in Patients With Complex Anatomy

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

TCT 337: Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

FDA Approves Pascal TEER Device for Degenerative MR

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

TCTMD’s Top 10 Most Popular Stories for June 2022

Tips and Tricks to Improve Leaflet Coaptation and Imaging During Tricuspid-TEER

Derivation and Validation of a Risk Score for COAPT-Ineligible Patients Undergoing Transcatheter Edge-To-Edge Repair - the CITE score

Outcomes of Transcatheter Mitral Valve Replacement Versus Edge-to-Edge Repair in Secondary Mitral Regurgitation Patients According to Adapted COAPT Inclusion Criteria

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content